about
Canine visceral leishmaniasis, United States and Canada, 2000-2003Seroprevalence and risk factors for canine visceral leishmaniasis in the endemic area of Dias D'Avila, State of Bahia, Brazil.Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis.Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE.Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogs.The prevalence of canine Leishmania infantum infection in western China detected by PCR and serological tests.Epidemiological Feature of Visceral Leishmaniasis in China, 2004-2012.Survey of Wild and Domestic Mammals for Infection with Leishmania infantum following an Outbreak of Desert Zoonotic Visceral Leishmaniasis in Jiashi, People's Republic of ChinaCurrent epidemiological profile and features of visceral leishmaniasis in people's republic of China.Optimal combinations of control strategies and cost-effective analysis for visceral leishmaniasis disease transmission.Prokaryotic expression and antigenic characterization of three recombinant Leishmania antigens for serological diagnosis of canine leishmaniasis.Presence of Leishmania amastigotes in peritoneal fluid of a dog with leishmaniasis from Alagoas, Northeast Brazil.Evaluation of parasitological examination, kDNA polymerase chain reaction and rK39-based immunochromatography for the diagnosis of visceral leishmaniasis in seropositive dogs from the screening-culling program in Brazil.Spatial and temporal trends of visceral leishmaniasis by mesoregion in a southeastern state of Brazil, 2002-2013.Validation of a recombinant based antibody ELISA for diagnosis of human and canine leishmaniasis.
P2860
Q24628232-26BD0C5C-B952-4172-AD49-E26294C8FE8FQ33391672-FFCC9E93-A32D-40B1-B75F-8AA6051805A7Q33788593-2FE3DD30-D150-4299-946C-4B5535755A12Q33870336-538B87A0-AFA0-475B-A9A6-8E0F0511BEC8Q34163466-21503CB1-575F-4910-9E95-F52FC43BEBAFQ35005771-72915E91-6834-40FB-A505-632031397710Q35668245-7925F293-CD36-436D-AA93-48C1DC894FB9Q35692382-405A190C-31F8-449C-9666-105785B1D359Q35850478-3F473849-787D-4D7E-B267-3F2AB714B5C7Q36286410-E52E4CD4-2C1F-46CE-B98E-EA68A0218377Q40172693-1C29F2C6-A7D4-47D7-B50B-0A8747D03424Q40267741-D59411EC-964A-4373-B51B-67F05CBB4578Q41736240-6C655FB9-F361-423F-B55C-31CE7B1A746AQ42680006-86F64991-5410-44C0-9830-FA1FBD7E85CDQ51685262-214EDF47-72A4-4D69-83A4-A62AD577F5A8
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Canine leishmaniasis: novel strategies for control.
@ast
Canine leishmaniasis: novel strategies for control.
@en
Canine leishmaniasis: novel strategies for control.
@nl
type
label
Canine leishmaniasis: novel strategies for control.
@ast
Canine leishmaniasis: novel strategies for control.
@en
Canine leishmaniasis: novel strategies for control.
@nl
prefLabel
Canine leishmaniasis: novel strategies for control.
@ast
Canine leishmaniasis: novel strategies for control.
@en
Canine leishmaniasis: novel strategies for control.
@nl
P1476
Canine leishmaniasis: novel strategies for control.
@en
P2093
Clive R Davies
P304
P356
10.1016/S1471-4922(02)02296-1
P577
2002-07-01T00:00:00Z